JDRF T1D Fund

JDRF T1D Fund

JDRF T1D Fund

Follow us
$4,500,000 Seed fund
FinSMEs

DiogenX Raises €4.5M in Seed Financing

$55,000,000 Venture capital (Series C)
FinSMEs , Pulse 2.0

Bigfoot Biomedical Closes $55M Series C Financing

$65,000,000 Venture capital (Series D)
Forbes

This MIT PhD Just Raised $65 Million For His Clinical Stage Cell Therapy Company

$4,000,000 Seed fund
FinSMEs , Pulse 2.0

i2O Therapeutics Raises $4m in Seed Funding

FinSMEs

Pandion Therapeutics Closes $80M Series B Financing

$130,000,000 Venture capital (Series B)
Pulse 2.0

Clinical-Stage T Cell Receptor Biotech Company Immunocore Raises Over $130 Million

$10,000,000 Venture capital (Series A)
PE HUB

IM Therapeutics locks in $10 mln Series A

Undisclosed funding
PE HUB

Pandion Therapeutics lands funding

Xconomy , MedCity News

Roche and SQZ Biotech Expand R&D Pact in Pursuit of New Cancer Drugs

Undisclosed funding
PE HUB

ImmusanT rakes in funding

$72,000,000 Venture capital (Series C)
FinSMEs

Cell Therapy Company SQZ Biotechnologies Completes $72M Series C Financing

Funding Health Science
$55,000,000 Venture capital (Series B)
FinSMEs , PE HUB , MedCity News

Bigfoot Biomedical Closes $55M Series B Financing

Funding Health
Xconomy

ImmusanT Gets $40M From Arch, Vatera to Continue Celiac Vaccine Quest

Health
$30,000,000 Venture capital
Drug Delivery Business , Crain's Cleveland Business

Diasome lands $30m to fund clinical trials of liver-targeted insulin

Undisclosed funding
PE HUB

Biopharma company TetraGenetics grabs funding

Health Funding
Venture capital
FinSMEs

Semma Therapeutics Raises Additional Funding

$2,000,000 Grant
Drug Delivery Business , PE HUB

JDRF backs GluSense with $2m grant

$4,000,000 Venture capital (Series B)
FinSMEs

SQZ Biotech Raises Further $4M in Series B Funding

$5,000,000 Grant
FinSMEs , businesswire

Semma Therapeutics Receives $5M Grant from California Institute of Regenerative Medicine

$1,540,000 Grant
FinSMEs

Tetragenetics Receives $1.54m Grant from NIGMS

Science Health